UBS AM’s Delcath Systems DCTH Stock Holding History

UBS AM’s Portfolio DCTH Stock Details DCTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.46K	Hold	354	–	–	﹤0.01%	3416
2026 Q1	$3.29K	Buy	+354	New	+$3.43K	﹤0.01%	3523

Other funds holding DCTH

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Algert Global San Francisco, California $8.43B AUM 80.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS AM's DCTH Position: Q2 2026 in Review

UBS AM held its Delcath Systems (DCTH) position steady in Q2 2026 at 354 shares worth $4.46K. The position accounts for ﹤0.01% of the portfolio, ranked #3416.

UBS AM first reported a position in DCTH in Q1 2026 and has held it in 2 quarters since. 120 funds tracked by Wall St. Rank hold DCTH as of Q2 2026.

UBS AM held 354 shares of Delcath Systems worth $4.46K as of Q2 2026.
UBS AM left its Delcath Systems share count unchanged in Q2 2026.
Delcath Systems made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3416 holding.
UBS AM first reported a position in Delcath Systems in Q1 2026 and has held it in 2 quarters since.
120 funds tracked by Wall St. Rank held Delcath Systems as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.